Patents by Inventor William Eric Frietze

William Eric Frietze has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Imidazo-triazines as corticotropin releasing factor antagonists
    Publication number: 20040023965
    Abstract: The present invention describes novel imidazo-triazines of formula I: 1
    Type: Application
    Filed: April 29, 2003
    Publication date: February 5, 2004
    Inventors: Paul Joseph Gilligan, Richard Eric Olson, William Eric Frietze
  • Isoxazolo [4,5-d] pyrimidines as CRF antagonists
    Patent number: 6589958
    Abstract: The present invention describes novel isoxazolo[1,5-a]pyrimidines of formula: wherein R is an aromatic or heteroaromatic ring, or pharmaceutically acceptable salt form thereof, which are useful as CRF antagonists.
    Type: Grant
    Filed: March 27, 2002
    Date of Patent: July 8, 2003
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventor: William Eric Frietze
  • Isoxazolo [4,5-d] pyrimidines as CRF antagonists
    Publication number: 20030114451
    Abstract: The present invention describes novel isoxazolo[1,5-a]pyrimidines of formula: 1
    Type: Application
    Filed: March 27, 2002
    Publication date: June 19, 2003
    Inventor: William Eric Frietze
  • Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
    Patent number: 6579876
    Abstract: The present invention describes novel compounds of formula (Ib): wherein D is aryl or heteroaryl or pharmaceutically acceptable salt forms thereof, which are useful as corticotropin releasing factor antagonists.
    Type: Grant
    Filed: February 11, 2002
    Date of Patent: June 17, 2003
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Paul Joseph Gilligan, Richard Eric Olson, William Eric Frietze
  • Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
    Publication number: 20030055059
    Abstract: The present invention describes novel imidazo-pyridines, -pyridazines, and -triazines of formula I: 1
    Type: Application
    Filed: February 11, 2002
    Publication date: March 20, 2003
    Inventors: Paul Joseph Gilligan, Richard Eric Olson, William Eric Frietze
  • Imidazo-pyridines as corticotropin releasing factor antagonists
    Patent number: 6521636
    Abstract: The present invention describes novel imidazo-pyridines of formula I: wherein D is aryl or heteroaryl or pharmaceutically acceptable salt forms thereof, which are useful as corticotropin releasing factor antagonists.
    Type: Grant
    Filed: July 25, 2000
    Date of Patent: February 18, 2003
    Assignee: Bristol-Myers Squibb Company
    Inventors: Paul Joseph Gilligan, Richard Eric Olson, William Eric Frietze
  • Pyrazolo[1,5-A]triazine corticotropin releasing factor antagonists
    Patent number: 6509338
    Abstract: The present invention describes novel pyrazolo[1,5-a]triazines of formula: wherein R3 is an alkyl, alkenyl, alkynyl, or cycloalkyl group, or pharmaceutically acceptable salt forms thereof, which are useful as CRF antagonists.
    Type: Grant
    Filed: June 14, 1999
    Date of Patent: January 21, 2003
    Assignee: Bristol-Myers Squibb Company
    Inventors: Richard Eric Olson, William Eric Frietze
  • Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
    Patent number: 6365589
    Abstract: The present invention describes novel imidazo-pyridines, -pyridazines, and -triazines of formula I: wherein A and B can be C or N and D is aryl or heteroaryl or pharmaceutically acceptable salt forms thereof, which are useful as CRF antagonists.
    Type: Grant
    Filed: June 25, 1999
    Date of Patent: April 2, 2002
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Paul Joseph Gilligan, Richard Eric Olson, William Eric Frietze
  • Isoxazolo [4,5-d] pyrimidines as CRF antagonists
    Publication number: 20020013461
    Abstract: The present invention describes novel isoxazolo[1,5-a]pyrimidines of formula: 1
    Type: Application
    Filed: July 25, 2001
    Publication date: January 31, 2002
    Inventor: William Eric Frietze
  • Isoxazolo[4, 5-D]pyrimidines as CRF antagonists
    Patent number: 6294671
    Abstract: The present invention describes novel isoxazolo[1,5-a]pyrimidines of formula: wherein R is an aromatic or heteroaromatic ring, or pharmaceutically acceptable salt form thereof, which are useful as CRF antagonists.
    Type: Grant
    Filed: August 20, 1999
    Date of Patent: September 25, 2001
    Assignee: DuPont Pharmaceuticals Company
    Inventor: William Eric Frietze